Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Turku University Hospital | OTHER_GOV |
| Hospital District of Helsinki and Uusimaa | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
The specific objectives of this project are:
The project includes a Rheumatoid sub-study where the main objective is to compare arthritic tissue and peripheral blood constituents between OA and rheumatoid arthritis patients to explore the differences in the disease mechanisms.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OA cases | Fifty adult patients who have hip osteoarthritis. |
| |
| RA cases | Forty adult patients who have rheumatoid arthritis in the hip joint. |
| |
| Non-arthritic controls | Twenty adult patients who go through trauma-based emergency total hip arthroplasty and do not have arthritis. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Total hip arthroplasty | Procedure | Hip joint replacement surgery. Elective for RA and OA cases. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Characterization of cell populations in OA | Characterization of cell populations found in different synovial tissues and blood derived samples of OA patients utilising single-cell RNA sequencing solutions. | Starting during the first quarter of 2025, ending by the last quarter of 2026. |
| Comparison of cell populations between OA cases and controls | The investigators will determine how the cell composition differs between arthritic and corresponding non-arthritic tissues utilising single-cell RNA sequencing solutions. | Starting during the first quarter of 2025, ending by the last quarter of 2026. |
| Cellular landscape in OA | The investigators will map the transcriptional, regulatory and protein landscape of OA at single-cell and tissue (spatial) level. | Starting during the last quarter of 2024, ending by the last quarter of 2026. |
| Key molecular pathways of OA | The investigators will determine what are the key molecular pathways activated in OA. | Starting during the last quarter of 2025, ending by the last quarter of 2027. |
| Comparison of disease mechanisms between RA and OA | In the Rheumatoid sub-study the investigators will explore the differences in the disease mechanisms between OA and RA by comparing synovial tissues and peripheral blood sample constituents. | Starting during the last quarter of 2024, ending by the last quarter of 2028. |
| Measure | Description | Time Frame |
|---|---|---|
| Biomarkers for OA | The investigators will investigate if some of the blood-derived immune cell populations or their products could be used as biomarkers for OA. | Starting during the second half of 2026, ending by the last quarter of 2028. |
| OA endotypes |
Not provided
Inclusion Criteria for the main (OA) study:
Cases: Adult patients with osteoarthritis in the hip joint and who are going through an elective total hip arthroplasty.
Controls: Non-arthritis adult patients who are going through a trauma-based emergency total hip arthroplasty.
----
Inclusion Criteria for the Rheumatoid sub-study:
Adult patients with rheumatoid arthritis in the hip joint and who are going through an elective total hip arthroplasty.
----
Exclusion Criteria:
For the Rheumatoid sub-study, the exclusion criteria are the same as above except for the RA.
Not provided
Not provided
Adult patients of the HUS (Joint Authority of the Helsinki and Uusimaa Hospital District) Center of Arthroplasty and the Orto Surgical Hospital of Turku University.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lea Mikkola, PhD | Contact | +358404143300 | limikk@utu.fi |
| Name | Affiliation | Role |
|---|---|---|
| Lea Mikkola, PhD | Turku Bioscience, University of Turku | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| PET-centre, University of Turku | Active, not recruiting | Turku | Southwest Finland | Finland | ||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Result | Rydgren E, Kotilainen SK, Piipponen M, Lönnberg T, Mikkola L. COMPARISON OF TWO HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS TECHNOLOGIES TO STUDY SYNOVIAL IMMUNE INFILTRATION IN OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS Osteoarthritis and Cartilage, Volume 33, Issue 6, 2025, page 816. https://doi.org/10.1016/j.joca.2025.03.079 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015207 | Osteoarthritis, Hip |
| D001172 | Arthritis, Rheumatoid |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019644 | Arthroplasty, Replacement, Hip |
| ID | Term |
|---|---|
| D019643 | Arthroplasty, Replacement |
| D001178 | Arthroplasty |
| D019637 | Orthopedic Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Hip joint synovial tissues and bone, peripheral blood mononuclear cells, serum, plasma, and whole blood.
The investigators aim to identify and further differentiate OA endotypes by utilizing the single-cell and spatial data. |
| Starting during the first half of 2025, ending by the second half of 2027. |
| Turku Bioscience, University of Turku |
| Active, not recruiting |
| Turku |
| Southwest Finland |
| Finland |
| Turku University Hospital | Recruiting | Turku | Southwest Finland | Finland |
|
| Helsinki University Hospital | Recruiting | Espoo | Uusimaa | Finland |
|
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D019651 | Plastic Surgery Procedures |
| D019919 | Prosthesis Implantation |